Patents Examined by Traviss McIntosh
  • Isoflavone and triterpene glycosides from soybeans
    Patent number: 7112573
    Abstract: The invention provides new isoflavonoid and triterpenoid compounds isolated from a soybean phytochemical concentrate. The new compounds have exhibited cytotoxic activity against selected tumor cell lines. Pharmaceutical compositions comprising the new compounds and methods for use thereof are provided by the invention.
    Type: Grant
    Filed: April 19, 2002
    Date of Patent: September 26, 2006
    Assignee: Iowa Research, The University Foundation
    Inventors: John P. N. Rosazza, Mohammed Hosny
  • Use of glycuronic polysaccharides and oligosaccharides as phytosanitary products and/or fertiliser
    Patent number: 7112555
    Abstract: This invention concerns the use of compounds selected among 1,4?-D-glucuronans, and/or glycuronic polysaccharides derived from polymers of formula (I), and whereof the number of saccharide units is less than about 30, and/or esters and/or ethers corresponding to polymers of formula (I) or said oligosccahride derivatives, as phytosanitary products in applications related to their activity for amplifying the 1,3?-D-glucanase enzyme, and/or the 1,4?-D-glucanase, and/or the xyloglucan endotransglycolase.
    Type: Grant
    Filed: June 23, 2000
    Date of Patent: September 26, 2006
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Yvette Lienart, Alain Heyraud, Olivier Sevenou
  • Substituted benzimidazole-, Benztriazole-, and benzimidazolone-O-glucosides
    Patent number: 7094764
    Abstract: This invention relates to to substituted benzimidazole-O-glucosides, benztriazole-O-glucosides, and benzimidazolone-O-glucosides, compositions containing them, and methods of using them, for example, for the treatment or prophylaxis of diabetes and Syndrome X.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: August 22, 2006
    Assignee: Janssen Pharmaceutica N.V.
    Inventor: Maud Urbanski
  • Medicament for treating lung cancer
    Patent number: 7091189
    Abstract: By using a combination of amrubicin or a pharmaceutically acceptable salt thereof with another medicament for treating lung cancer (irinotecan, vinorelbine, gemcitabine, etc.), it is intended to provide medicaments for treating lung cancer having an improved antitumor therapeutic effect on lung cancer and reduced side effects. Lung cancer can be effectively treated using these medicaments.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: August 15, 2006
    Inventors: Toshihiro Noguchi, Akemi Baba
  • Antimicrobial quaternary surfactants based upon alkyl polyglycoside
    Patent number: 7084129
    Abstract: The invention relates to a series of polyglycoside derivatives that contain water-soluble cationic groups introduced into the molecule by reaction with the hydroxyl groups present in the starting polyglycoside molecule, with an epoxy cationic material. The materials are multifunctional, providing not only wetting, and conditioning, but also antimicrobial properties, making them ideal for personal care applications.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: August 1, 2006
    Assignee: Colonial Chemical
    Inventors: Dean A. Smith, David Anderson, Anthony J. O'Lenick, Jr.
  • Methods and compositions for enhancing cellular function through protection of tissue components
    Patent number: 7084126
    Abstract: Methods and composisions for enhancing cellular function through protection of a tissue components such receptors, proteins, lipids, nucleic acids, carbohydrates, hormones, vitamins, and cofactors, by administering pyrophosphate analogs or related compounds.
    Type: Grant
    Filed: April 27, 2001
    Date of Patent: August 1, 2006
    Assignee: HealthPartners Research Foundation
    Inventors: William H. Frey, II, John Randall Fawcett
  • Oral treatment of companion animals with ectoparasiticidal spinosyns
    Patent number: 6664237
    Abstract: The invention provides single-dose oral formulations for controlling an ectoparasite infestation on a companion animal for a prolonged time, said formulations comprising a spinosyn component, or a physiologically acceptable derivative or salt thereof, and a carrier in oral dosage form. It also provides methods for controlling such infestations comprising orally administering a single dose of these formulations to the animal.
    Type: Grant
    Filed: January 24, 2002
    Date of Patent: December 16, 2003
    Assignee: Eli Lilly and Company
    Inventor: Daniel Earl Snyder
  • Method for the treatment or prevention of viral infection using nucleoside analogues
    Patent number: 6583149
    Abstract: Compounds of formula I: wherein Y, X, R1 and Ra are defined herein are in methods for treating or preventing a viral infections selected from herpes simplex virus, varicella zoster virus, respiratory syncytial virus and cytomegalovirus infections.
    Type: Grant
    Filed: September 22, 2000
    Date of Patent: June 24, 2003
    Assignee: BioChem Pharma Inc.
    Inventors: Francis J. Giles, Jean Bédard, Robert F. Rando
  • Method of treating arrhythmias
    Patent number: 6537974
    Abstract: A method for treating arrhythmia in mammals is provided comprising administering a low dose of an adenosine receptor agonist of the Formula I: wherein R1 is an optionally substituted heterocyclic group, preferably monocyclic.
    Type: Grant
    Filed: September 7, 2001
    Date of Patent: March 25, 2003
    Assignee: CV Therapeutics, Inc.
    Inventor: Andrew Wolff